Clinical Trial Update: Longitudinal Study of Biomarkers

View source ↗

Summary

A completed longitudinal biomarker study in Central Nervous System Tumors sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Central Nervous System Tumor | Status: COMPLETED